Skip to content

High Sensitive Troponin T (hsTnT) and Copeptin as Prognostic Parameters in Patients With Elective Total Endoprosthesis

High Sensitive Troponin T (hsTnT) and Copeptin as Prognostic Parameters in Patients With Elective Knee and Hip Endoprosthesis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01335815
Enrollment
200
Registered
2011-04-14
Start date
2011-03-31
Completion date
2013-03-31
Last updated
2011-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Myocardial Infarctions, Pulmonary Embolism

Brief summary

Summary: The purpose of the study is to prove if the biomarker high sensitive troponin T (hsTnT) and the biomarker of endogenous stress copeptin can serve as surrogate parameter of prognosis in patients with elective knee and hip total endoprosthesis.

Detailed description

Consecutively, high sensitive troponin T and copeptin will be measured in all patients with elective knee and hip endoprosthesis in the orthopedic department of the University of Heidelberg. The blood is taken during the routine blood testes if possible, on admission and the days 1-4 following the operation. Usual baseline characteristics are taken as well as usual blood results (hb, cholesterol and so on). Primary endpoint is the detection of perioperative myocardial infarction and pulmonary embolism.

Interventions

None listed

Sponsors

Heidelberg University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Consecutive patients with elective knee and hip endoprosthesis

Exclusion criteria

* Not willing or not able to take part in the observational trial * No written inform consent

Design outcomes

Primary

MeasureTime frame
Prevalence of perioperative myocardial infarction and pulmonary embolismUntil 96h after operation

Countries

Germany

Contacts

Primary Contactevangelos Giannitsis, Prof. Dr.
Evangelos_Giannitsis@med.uni-heidelberg.de0049-6221-56-38686

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026